IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 360 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,578,000 | +260.3% | 42,634 | +450.5% | 0.08% | +162.5% |
| Q4 2020 | $438,000 | -92.0% | 7,744 | -93.3% | 0.03% | -82.1% |
| Q3 2020 | $5,492,000 | -25.2% | 115,751 | -7.1% | 0.18% | -5.8% |
| Q2 2020 | $7,345,000 | +88.6% | 124,569 | +51.2% | 0.19% | +84.5% |
| Q1 2020 | $3,894,000 | -47.1% | 82,360 | -32.4% | 0.10% | 0.0% |
| Q4 2019 | $7,362,000 | +346.5% | 121,864 | +342.8% | 0.10% | +442.1% |
| Q3 2019 | $1,649,000 | +254.6% | 27,524 | +280.3% | 0.02% | +111.1% |
| Q2 2019 | $465,000 | – | 7,238 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |